XML 18 R6.htm IDEA: XBRL DOCUMENT v3.23.4
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities:    
Net loss from continuing operations $ (2,004,581) $ (1,983,743)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 8,464 11,815
Options expense 25,978 67,439
Common stock issued for services 79,299 107,430
Bad debt recovery (98,841)
Gain on disposal of asset (4,100)
Amortization of intangible assets 325,916 29,400
Changes in operating assets and liabilities:    
Accounts receivable, net (212,292) 227,508
Prepaid assets and deposits (138,450) 198,088
Inventory (39,013) (19,671)
Other receivables (875,250)
Operating lease right-of-use assets 152,121 132,847
Other assets
Operating lease liabilities (145,707) (120,401)
Accounts payable 854,171 267,384
Accrued liabilities 43,729 (178,714)
Inventory deposits
Current liabilities (5,127) 105,926
Warrant liability 443,308
Net cash used in operating activities from continuing operations (612,184) (2,132,883)
Net cash used in operating activities from discontinued operations (593,893) (623,096)
Net cash used in operating activities (1,206,077) (2,755,979)
Cash flows from investing activities:    
Proceeds from sale of fixed assets 23,000
Cash received in acquisitions 5,546
Investment in capitalized software (335,902)
Net cash provided by (used in) investing activities from continuing operations 5,546 (312,902)
Net cash provided by investing activities from discontinued operations 68,737
Net cash provided by (used in) investing activities 74,283 (312,902)
Cash flows from financing activities:    
Proceeds from the issuance of debt 200,000
Proceeds from repayment of notes receivable 25,000
Repayment of contingent liability (1,755,688) (282,857)
Proceeds from sale of future revenue 2,100,000 825,000
Distributions to non-controlling interest (275,000)
Proceeds from exercise of warrants 1,622 875
Net cash provided by financing activities from continuing operations 570,934 268,018
Net cash used in financing activities from discontinued operations (500,000)
Net cash provided by financing activities 70,934 268,018
Net change in cash (1,060,860) (2,800,863)
Cash at beginning of the year 1,094,891 3,122,578
Cash at end of the period 34,031 321,715
Supplemental disclosure of cash flow information    
Cash paid for interest 494,408 3,328
Cash paid for income taxes
Non-cash Transactions    
Insurance premium financed 306,152 220,354
Note cancelled from SOSRx agreement termination 500,000
Note issued as SOSRx contribution 500,000
Intangible asset contribution from non-controlling interest 792,500
Disposition of assets, related party 492,030
Issuance of notes receivable $ 1,300,000